Related Content
June 18, 2012 — St. Jude Medical Inc. announced it has received U.S. Food and Drug Administration (FDA) clearance and ...
June 18, 2012
May 31, 2012 — Occlutech GmbH, a European developer of minimally invasive implants for the treatment of structural heart ...
May 31, 2012
Feature | Dave Fornell
The latest trends and newest cardiac rhythm management technology were highlighted during the biggest electrophysiology ...
May 24, 2012
May 23, 2012 — St. Jude Medical Inc. announced U.S. Food and Drug Administration (FDA) approval of its Ellipse ...
May 23, 2012
Data was presented during the Heart Rhythm Society (HRS) 2012 scientific sessions that showed the Riata ICD lead had a ...
May 22, 2012
Diagnostic and Interventional Cardiology Editor Dave Fornell shows some of the most innovative new technology displayed ...
May 22, 2012May 21, 2012 -- St. Jude Medical Inc. announced that data from the FAME II trial demonstrated a significant difference ...
May 21, 2012May 18, 2012 -- St. Jude Medical Inc., a global medical device company, announced that preliminary data demonstrated the ...
May 18, 2012
May 15, 2012 – St. Jude Medical Inc. announced CE mark approval and launch of its EnligHTN renal denervation system ...
May 15, 2012
May 11, 2012 — St. Jude Medical Inc. announced U.S. Food and Drug Administration (FDA) approval of its Assura portfolio ...
May 11, 2012© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now